+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Proton Therapy Market Size, Share & Industry Trends Analysis Report By Product Type, By Indication (CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Others), By End User, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 96 Pages
  • August 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5658889
The Latin America, Middle East and Africa Proton Therapy Market is expected to witness market growth of 15.1% CAGR during the forecast period (2022-2028).

The therapy was delivered by passive scattering in the first available commercial proton delivery systems. In scattering proton treatment, scattering devices spread out the proton beam, which is then shaped by placing objects like collimators and compensators in the beam's path. The target volume receives a homogenous dosage from passive scattering. Passive scattering hence offers less control over dosage distributions close to the target.

Pencil beam scanning has been included in several scattering therapy systems throughout time. Since scattering therapy was the first type of proton therapy to be made available, scattering technology was used to gather the majority of clinical data on proton therapy, particularly long-term data as of 2020. Pencil beam scanning is a more recent and adaptable delivery technique that employs a beam that sweeps horizontally over the target to give the required dose while closely mimicking the shape of the tumor.

This conformal delivery is accomplished without the use of apertures or compensators by magnetically scanning small proton beamlets to shape the dose. Multiple beams are delivered from various angles, and magnets in the treatment nozzle direct the proton beam as the dose is applied layer by layer to conform to the target volume. The proton dose can be delivered with greater control and flexibility using this sort of scanning delivery, allowing it to perfectly fit the geometry of the tumor.

The United Arab Emirates (UAE), which has one of the fastest-growing economies in the world, has seen an increase in non - communicable disease including cancer. Despite screening and early diagnosis measures that seem to be far from the objective inclusion of the intended respondents, the number of illnesses and deaths in the UAE has been rising over time. The UAE's cancer control strategy is being designed with specific aims and objectives in mind, adhering to the recommendations of the WHO and EMRO. The objectives include treating cancer, lowering cancer incidence, managing mortality, and improving the prognosis and quality of life for cancer patients.

The Brazil market dominated the LAMEA Proton Therapy Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $16,637.2 Thousands by 2028. The Argentina market is anticipated to witness a CAGR of 15.7% during (2022 - 2028). Additionally, The UAE market is expected to witness a CAGR of 14.8% during (2022 - 2028).

Based on Product Type, the market is segmented into Accelerator, Beam Delivery System, Beam Transport System, Nozzle & Image Viewers and Patient Positioning System. Based on Indication, the market is segmented into CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Others. Based on End User, the market is segmented into Hospitals, Proton Therapy Centers and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Toshiba Corporation, Siemens Healthineers AG (Siemens AG), Ion Beam Applications SA, Hitachi, Ltd., Mirion Technologies, Inc., Mevion Medical Systems, Inc., Provision Healthcare, Sumitomo Corporation and Optivus Proton Therapy, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Product Type
  • Accelerator
  • Beam Delivery System
  • Beam Transport System
  • Nozzle & Image Viewers
  • Patient Positioning System
By Indication
  • CNS Cancer
  • Prostate Cancer
  • Head & Neck Cancer
  • Breast Cancer
  • Others
By End User
  • Hospitals
  • Proton Therapy Centers
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Toshiba Corporation
  • Siemens Healthineers AG (Siemens AG)
  • Ion Beam Applications SA
  • Hitachi, Ltd.
  • Mirion Technologies, Inc.
  • Mevion Medical Systems, Inc.
  • Provision Healthcare
  • Sumitomo Corporation
  • Optivus Proton Therapy, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Proton Therapy Market, by Product Type
1.4.2 LAMEA Proton Therapy Market, by Indication
1.4.3 LAMEA Proton Therapy Market, by End User
1.4.4 LAMEA Proton Therapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Proton Therapy Market
Chapter 4. LAMEA Proton Therapy Market by Product Type
4.1 LAMEA Accelerator Market by Country
4.2 LAMEA Beam Delivery System Market by Country
4.3 LAMEA Beam Transport System Market by Country
4.4 LAMEA Nozzle & Image Viewers Market by Country
4.5 LAMEA Patient Positioning System Market by Country
Chapter 5. LAMEA Proton Therapy Market by Indication
5.1 LAMEA CNS Cancer Market by Country
5.2 LAMEA Prostate Cancer Market by Country
5.3 LAMEA Head & Neck Cancer Market by Country
5.4 LAMEA Breast Cancer Market by Country
5.5 LAMEA Others Market by Country
Chapter 6. LAMEA Proton Therapy Market by End User
6.1 LAMEA Hospitals Market by Country
6.2 LAMEA Proton Therapy Centers Market by Country
6.3 LAMEA Others Market by Country
Chapter 7. LAMEA Proton Therapy Market by Country
7.1 Brazil Proton Therapy Market
7.1.1 Brazil Proton Therapy Market by Product Type
7.1.2 Brazil Proton Therapy Market by Indication
7.1.3 Brazil Proton Therapy Market by End User
7.2 Argentina Proton Therapy Market
7.2.1 Argentina Proton Therapy Market by Product Type
7.2.2 Argentina Proton Therapy Market by Indication
7.2.3 Argentina Proton Therapy Market by End User
7.3 UAE Proton Therapy Market
7.3.1 UAE Proton Therapy Market by Product Type
7.3.2 UAE Proton Therapy Market by Indication
7.3.3 UAE Proton Therapy Market by End User
7.4 Saudi Arabia Proton Therapy Market
7.4.1 Saudi Arabia Proton Therapy Market by Product Type
7.4.2 Saudi Arabia Proton Therapy Market by Indication
7.4.3 Saudi Arabia Proton Therapy Market by End User
7.5 South Africa Proton Therapy Market
7.5.1 South Africa Proton Therapy Market by Product Type
7.5.2 South Africa Proton Therapy Market by Indication
7.5.3 South Africa Proton Therapy Market by End User
7.6 Nigeria Proton Therapy Market
7.6.1 Nigeria Proton Therapy Market by Product Type
7.6.2 Nigeria Proton Therapy Market by Indication
7.6.3 Nigeria Proton Therapy Market by End User
7.7 Rest of LAMEA Proton Therapy Market
7.7.1 Rest of LAMEA Proton Therapy Market by Product Type
7.7.2 Rest of LAMEA Proton Therapy Market by Indication
7.7.3 Rest of LAMEA Proton Therapy Market by End User
Chapter 8. Company Profiles
8.1 Toshiba Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research and Development Expense
8.1.5 SWOT Analysis
8.2 Siemens Healthineers AG (Siemens AG)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisitions and Mergers:
8.2.6 SWOT Analysis
8.3 Ion Beam Applications SA
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Acquisition and Mergers:
8.4 Hitachi, Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Mirion Technologies, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 Mevion Medical Systems, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 Provision Healthcare
8.7.1 Company Overview
8.8 Sumitomo Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.9 Optivus Proton Therapy, Inc.
8.9.1 Company Overview

Companies Mentioned

  • Toshiba Corporation
  • Siemens Healthineers AG (Siemens AG)
  • Ion Beam Applications SA
  • Hitachi, Ltd.
  • Mirion Technologies, Inc.
  • Mevion Medical Systems, Inc.
  • Provision Healthcare
  • Sumitomo Corporation
  • Optivus Proton Therapy, Inc.

Methodology

Loading
LOADING...